labetalol has been researched along with Cocaine-Related Disorders in 4 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
Cocaine-Related Disorders: Disorders related or resulting from use of cocaine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Labetalol treatment significantly attenuated the cocaine-induced increases in heart rate and systolic blood pressure." | 2.69 | Effects of labetalol treatment on the physiological and subjective response to smoked cocaine. ( Babb, DA; Brown, S; Hatsukami, DK; Pentel, PR; Sofuoglu, M, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Richards, JR | 2 |
| Lange, RA | 2 |
| Arnold, TC | 1 |
| Horowitz, BZ | 1 |
| Hoskins, MH | 1 |
| Leleiko, RM | 1 |
| Ramos, JJ | 1 |
| Sola, S | 1 |
| Caneer, PM | 1 |
| Khan, BV | 1 |
| Sofuoglu, M | 1 |
| Brown, S | 1 |
| Babb, DA | 1 |
| Pentel, PR | 1 |
| Hatsukami, DK | 1 |
1 trial available for labetalol and Cocaine-Related Disorders
| Article | Year |
|---|---|
Effects of labetalol treatment on the physiological and subjective response to smoked cocaine.
Topics: Adrenergic Antagonists; Behavior, Addictive; Blood Pressure; Cocaine; Cocaine-Related Disorders; Cra | 2000 |
3 other studies available for labetalol and Cocaine-Related Disorders
| Article | Year |
|---|---|
Labetalol and cardiovascular consequences of cocaine use.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Cardiovascular Diseases; Cocaine; Cocaine-Related Diso | 2016 |
Dual cocaine and methamphetamine cardiovascular toxicity: rapid resolution with labetalol.
Topics: Administration, Intravenous; Adrenergic beta-Antagonists; Amphetamine-Related Disorders; Anti-Anxiet | 2017 |
Effects of labetalol on hemodynamic parameters and soluble biomarkers of inflammation in acute coronary syndrome in patients with active cocaine use.
Topics: Acute Coronary Syndrome; Adrenergic alpha-Antagonists; Adult; Aged; Biomarkers; Cardiovascular Agent | 2010 |